 REHOVOT, Israel, May 12, 2021 PRNewswire -- Evogene Ltd. NASDAQ: EVGN TASE: EVGN, a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the first quarter of 2021 on Wednesday, May 26 th, 2021. 